The onset of side effects and the importance of achieving the therapeutic
target in patients at risk of cardiovascular events suggest the
need to find alternative therapeutic approaches.
Experimental and epidemiological evidence suggests that dietary
polyphenols, in particular flavonoids,may play a role in ameliorating atherosclerosis,
due to a pleiotropic anti-oxidative and anti-inflammatory
effect proposed as underlying mechanism [22].